9:15 AM ET
8-K
Leadership Change
Apimeds Pharmaceuticals US Leadership Change
Apimeds Pharmaceuticals US, Inc. appointed Eric Sherb as Chief Financial Officer, effective October 1, 2026, succeeding Erick Frim who resigned as Interim CFO. Mr. Sherb, a CPA with 18 years of experience, will receive an annual base salary of $60,000 under his new employment agreement. The company stated that Mr. Frim's resignation was not due to any disagreements regarding operations, policies, or practices.